Citigroup’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.5M Buy
357,381
+285,337
+396% +$37.2M 0.02% 787
2025
Q4
$8.76M Sell
72,044
-4,741
-6% -$595K 0.01% 1638
2025
Q3
$8.62M Buy
76,785
+33,414
+77% +$3.91M 0.01% 1604
2025
Q2
$5.81M Sell
43,371
-4,916
-10% -$540K ﹤0.01% 1764
2025
Q1
$3.25M Buy
48,287
+2,486
+5% +$171K ﹤0.01% 2289
2024
Q4
$2.86M Buy
45,801
+3,725
+9% +$347K ﹤0.01% 2498
2024
Q3
$6.61M Buy
42,076
+32,552
+342% +$5.02M 0.01% 1623
2024
Q2
$1.43M Buy
9,524
+3,790
+66% +$455K ﹤0.01% 2618
2024
Q1
$424K Sell
5,734
-5,638
-50% -$465K ﹤0.01% 3672
2023
Q4
$898K Buy
11,372
+4,390
+63% +$265K ﹤0.01% 2917
2023
Q3
$382K Sell
6,982
-5,573
-44% -$401K ﹤0.01% 3266
2023
Q2
$1.05M Buy
12,555
+10,216
+437% +$782K ﹤0.01% 2809
2023
Q1
$177K Buy
2,339
+1,134
+94% +$78.4K ﹤0.01% 3789
2022
Q4
$74.4K Buy
1,205
+8
+0.7% +$425 ﹤0.01% 4140
2022
Q3
$50K Sell
1,197
-1,202
-50% -$52.3K ﹤0.01% 4389
2022
Q2
$75K Buy
2,399
+670
+39% +$17.9K ﹤0.01% 4356
2022
Q1
$47K Sell
1,729
-5,304
-75% -$95K ﹤0.01% 4754
2021
Q4
$135K Buy
7,033
+3,691
+110% +$92.5K ﹤0.01% 4573
2021
Q3
$111K Buy
3,342
+1,483
+80% +$45.3K ﹤0.01% 4380
2021
Q2
$62K Sell
1,859
-1,928
-51% -$53.4K ﹤0.01% 4715
2021
Q1
$157K Sell
3,787
-1,135
-23% -$34.9K ﹤0.01% 4140
2020
Q4
$98K Buy
4,922
+3,715
+308% +$55K ﹤0.01% 5549
2020
Q3
$17K Sell
1,207
-1,466
-55% -$25.1K ﹤0.01% 6308
2020
Q2
$48K Sell
2,673
-1,441
-35% -$22.5K ﹤0.01% 6041
2020
Q1
$50K Buy
4,114
+1,258
+44% +$21.1K ﹤0.01% 5980
2019
Q4
$54K Buy
2,856
+2,552
+839% +$46.9K ﹤0.01% 6245
2019
Q3
$7K Sell
304
-1,521
-83% -$36.5K ﹤0.01% 7228
2019
Q2
$53K Buy
+1,825
New +$49.8K ﹤0.01% 6422

Other funds holding TMDX